About: http://webisa.webdatacommons.org/444034817

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The LUX-Lung 3 trial is the largest Phase III trial to date in first-line EGFR mutation-positive, advanced, metastatic NSCLC patients, and the first to use pemetrexed/cisplatin as a comparator in this population.
http://www.w3.org/ns/prov#wasQuotedFrom	biospace.com